Pages that link to "Q44782696"

The following pages link to Comorbid cannabis use and panic disorder: short term and long term follow-up study (Q44782696):

Displaying 25 items.

• The endocannabinoid system as an emerging target of pharmacotherapy (Q24648473) (← links)
• Endocannabinoid-mediated synaptic plasticity and addiction-related behavior (Q29042501) (← links)
• Cannabis use and anxiety: is stress the missing piece of the puzzle? (Q33359689) (← links)
• Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis (Q33664684) (← links)
• Exploring the mediational role of coping motives for marijuana use in terms of the relation between anxiety sensitivity and marijuana dependence (Q33901647) (← links)
• Cannabis and psychopathology : update 2004. (Q34180323) (← links)
• Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendations (Q34453438) (← links)
• Demographic and clinical characteristics of UK military veterans attending a psychological therapies service. (Q34589578) (← links)
• Barbexaclone abuse in a cannabis ex-user (Q34624891) (← links)
• Anxiety sensitivity as a mediator of the relationship between moderate-intensity exercise and coping-oriented marijuana use motives (Q34911006) (← links)
• Cannabis and anxiety: a critical review of the evidence (Q34998397) (← links)
• Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors (Q35532072) (← links)
• Relations between anxiety sensitivity, distress tolerance, and fear reactivity to bodily sensations to coping and conformity marijuana use motives among young adult marijuana users (Q35547884) (← links)
• Enhancement of endocannabinoid signaling and the pharmacotherapy of depression. (Q36184363) (← links)
• Modulation of fear and anxiety by the endogenous cannabinoid system (Q36748119) (← links)
• Endocannabinoid system and synaptic plasticity: implications for emotional responses (Q36887168) (← links)
• Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives. (Q36953261) (← links)
• Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder (Q37010082) (← links)
• Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment (Q37711124) (← links)
• THC and CBD oromucosal spray (Sativex®) in the management of spasticity associated with multiple sclerosis. (Q37860314) (← links)
• Difficulties in emotion regulation are associated with panic symptom severity following a quit attempt among cannabis dependent veterans (Q45083708) (← links)
• Does occasional cannabis use impact anxiety and depression treatment outcomes?: Results from a randomized effectiveness trial. (Q53130474) (← links)
• Mental health-related emergency department visits associated with cannabis in Colorado (Q55455281) (← links)
• Positive and Negative Effects of Cannabis and Cannabinoids on Health (Q91290912) (← links)
• Prescrire du cannabis fumé pour la douleur chronique non cancéreuse: Recommandations préliminaires (Q94359546) (← links)